What are the glycemic targets in hospitalized patients? Insulin therapy should be initiated for treatment of persistent hyperglycemia starting at...
What are the glycemic targets in hospitalized patients?
Insulin therapy should be initiated for treatment of persistent hyperglycemia starting at a threshold $180 mg/dL (10.0 mmol/L) (checked on two occasions). Once insulin therapy is started, a target glucose range of 140–180 mg/dL (7.8–10.0 mmol/L) is recommended for the majority of critically ill and noncritically ill patients.
More stringent goals, such as 110–140 mg/dL (6.1–7.8 mmol/L), may be appropriate for selected patients if they can be achieved without significant hypoglycemia.
Insulin therapy should be initiated for treatment of persistent hyperglycemia starting at a threshold $180 mg/dL (10.0 mmol/L) (checked on two occasions). Once insulin therapy is started, a target glucose range of 140–180 mg/dL (7.8–10.0 mmol/L) is recommended for the majority of critically ill and noncritically ill patients.
More stringent goals, such as 110–140 mg/dL (6.1–7.8 mmol/L), may be appropriate for selected patients if they can be achieved without significant hypoglycemia.
💡 1 Resposta
Ed 
As metas glicêmicas em pacientes hospitalizados podem variar dependendo do estado clínico do paciente. No geral, a terapia com insulina deve ser iniciada para o tratamento da hiperglicemia persistente a partir de um limite de 180 mg/dL (10,0 mmol/L) (verificado em duas ocasiões). Uma vez iniciada a terapia com insulina, é recomendado um intervalo de glicose-alvo de 140-180 mg/dL (7,8-10,0 mmol/L) para a maioria dos pacientes gravemente enfermos e não gravemente enfermos. Metas mais rigorosas, como 110-140 mg/dL (6,1-7,8 mmol/L), podem ser apropriadas para pacientes selecionados, desde que possam ser alcançadas sem hipoglicemia significativa.
✏️ Responder
Para escrever sua resposta aqui, entre ou crie uma conta
Outros materiais
Perguntas relacionadas
Materiais relacionados
3 pág.
8 pág.
Compartilhar